Charles Q Morris insider trades

Open-market stock purchases and sales by Charles Q Morris, Chief Medical Officer at Prelude Therapeutics Inc, from SEC Form 4 filings since Oct 20, 2010.

Recent trades

DateStockTradeValue
May 1, 2026PRLD Prelude Therapeutics IncBought (not open market)$2.1M

Companies traded

  • PRLD Prelude Therapeutics Inc: other filings, last May 1, 2026
  • LVTX LAVA Therapeutics NV: other filings, last Feb 13, 2025
  • RDUS Radius Health, Inc: 1 sale, last Feb 26, 2020
  • IMGN Immunogen Inc: 7 sales, last Jul 18, 2016
  • ALTH Allos Therapeutics Inc: 7 sales, last Sep 4, 2012

Get free alerts when Charles Q Morris files a new trade →